12月12日的北京迎来了今冬首场降雪。冒着纷飞的雪花，人民健康"五进"关爱服务计划走进中国石油化工集团有限公司（以下简称"中国石化"）总部， 将贴心的健康服务送至中国石化职工身边，在寒冬里筑起了一道温暖的防线。结合前期调研，本场"五进"计划围绕职工健康需求，提供了健康生活体验、健 康筛查、健康咨询等多项服务。 为更好地满足中国石化职工的健康需求，活动现场特别设置"名医健康咨询"环节，邀请北京协和医院呼吸与危重症学科主任医师罗金梅、北京协和医院 内分泌科主任医师平凡、北京协和医院心理医学科主任医师史丽丽以及北京协和医院妇科内分泌与生殖中心副主任医师王亚平为职工们一对一解答健康问 题，提供专业健康指导。 据了解，人民健康将继续联合中央有关单位、各地党委政府、大型企事业单位、权威社会组织，秉持"健康生活与您共享"的理念，持续推进人民健 康"五进"关爱服务计划。以主题教育活动为契机，通过走进机关、企业、社区、乡村、校园，把为民办实事作为重要内容，切实将惠民生、暖民心、顺民意 的工作做到群众的心坎上，走出一条具有中央媒体平台特色的健康中国、爱国卫生运动新型服务之路，不断提升人民群众的健康获得感和生活幸福感。 人民健康" ...

Core Viewpoint - The leading health technology platform, Qingsong Health Group, has officially passed the hearing for its IPO on the Hong Kong Stock Exchange, aiming to enhance its digital health services and insurance solutions through advanced technology [1][2] Group 1: Company Overview - Qingsong Health Group was established in 2014 and is recognized as a leading digital comprehensive health service and health insurance solution platform in China [1] - According to a report by Sullivan, Qingsong Health Group ranks seventh in China's digital health service market based on projected revenue for 2024 [1] Group 2: Service Offerings - The company provides a diverse range of personalized health services, including insurance products, health screenings, health consultations, medical appointment services, and health product sales, targeting users seeking comprehensive health solutions [1] - Qingsong Health Group leverages AI and other technologies to empower industry participants in creating high-quality health education content [1] Group 3: Technological Development - The company has developed its own AI technology stack, AIcare, which integrates artificial intelligence, big data, and cloud computing capabilities, applied across various business segments such as user services, intelligent risk control, personalized marketing, product innovation, and operational efficiency [1] - Through the continuous optimization of AIcare, Qingsong Health Group has achieved a deep and precise transformation of its health and insurance businesses, setting a new benchmark for "AI + Health" in the industry [1] Group 4: IPO Fund Utilization - The funds raised from the IPO are intended for ongoing research and development, strengthening AI technology infrastructure, expanding the digital health ecosystem, enhancing user experience, and pursuing international expansion to accelerate the realization of the long-term strategic goal of "technology empowering public health" [2]